在压力过载期间心脏蛋白质组的激活促进了心室缩
Christophe Depre1, Qian Wang, Lin Yan
1Department of Cell Biology & Molecular Medicine, UMDNJ, Newark, NJ 07103, USA.
Circulation
|October 18, 2006
概括
慢性压力过载会激活心脏中的蛋白酶体系统,这对于左心室缩 (LVH) 的发展至关重要. 这种蛋白酶激活是特定于心下内脏的,并且对于LVH的建立是必需的.
科学领域:
- 心血管生物学 心血管生物学
- 分子生物学分子生物学
- 蛋白质稳定性 蛋白质稳定性
背景情况:
- 心脏适应血动力学过载取决于蛋白质周转.
- 左心室缩 (LVH) 涉及复杂的分子适应.
- 研究了蛋白酶系统在LVH发展中的作用.
研究的目的:
- 为了确定慢性LVH是否会激活蛋白酶体系统,特别是在心下内脏.
- 为了调查蛋白酶体系统是否对LVH发育有必要.
主要方法:
- 在LVH的狗和小鼠模型中评估了蛋白酶子单元基因和蛋白质表达和活性.
- 利用大动脉带带来诱导慢性LVH.
- 在小鼠模型中使用蛋白酶体抑制剂epoxomicin.
主要成果:
- 与对照组相比,LVH心脏的蛋白质酶表达和活性在心脏下肠内显著增加.
- 这些变化是特定于心下内脏的,而不是在其他心脏或外围组织中观察到的.
- 在小鼠中,蛋白质酶抑制完全阻止了LVH的发展.
结论:
- 红下内心蛋白酶表达和活性增加是慢性压力过载的关键特征.
- 蛋白酶体系统是LVH发展的关键要求.
相关概念视频
Pathophysiology of Cardiac Performance
2.2K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.2K
Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cellular Adaptation II: Hypertrophy
54
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
54


